Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- ;
- University of Cambridge
- University of Oxford
- Cranfield University
- Imperial College London
- UNIVERSITY OF VIENNA
- University of Manchester
- ; Swansea University
- Abertay University
- Bangor University
- The University of Manchester
- UWE, Bristol
- University of Cambridge;
- University of Newcastle
- University of Sheffield
- 5 more »
- « less
-
Field
-
About the role This is an exciting opening for an Adult Physician with demonstrable expertise in controlled human infection models an exceptional track record in grant funding and publication
-
training and guidance to develop their molecular biology skills using state-of-the-art tools and resources. The post-holder will be expected to work collaboratively and independently to achieve the goals
-
undergraduate and postgraduate modules. Duties will include teaching law including the development of teaching resources and marking of assignments. The successful candidate will also be expected to provide
-
disassembly cells for repair and recycling. Better Quality of Life: Successful automation of dull, dirty, or dangerous tasks, like grinding and polishing, will relieve pressure on human workers, promoting a
-
practice, in addition to wellbeing, human resources, policy and service planning and design. The successful candidates will have the opportunity to work with national and international experts in workforce
-
as a fact of good care provision but as a marketable resource and yardstick for service delivery. Applications are invited for a 3-year full-time ESRC NWSSDTP CASE PhD studentship for a qualitative
-
. This studentship is funded through the Department’s new starter allocation. We recommend that you apply early as the advert will be removed once the position has been filled. Plastics production and disposal
-
on cell viability and DDR activation in established human cell models. The student will perform CRISPR screens to determine factors that affect resistance/sensitivity and follow these up with mechanistic
-
-energizing exhausted T cells, it is becoming apparent that many checkpoint drugs act on specific subsets of ‘stem like’ T cells, which are present in the lymph nodes, or other sites such as the tumour itself
-
contemporary high-resolution next-generation sequencing and array-based genomic and epigenomic datasets across large cohorts of human tumours and experimental models, alongside complex drug screening, efficacy